| |
| |
|
| Insider
Information: |
Meeker David P |
| Relationship: |
President and CEO, Dir... |
| City: |
Danbury |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
564,738 |
|
|
Indirect Shares
|
341,239 |
|
|
| Direct
Value |
$7,090,028 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
905,977 |
|
|
| Total
Value |
$7,090,028 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -52.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Penwest Pharmaceuticals Co |
PPCO |
Director |
2010-09-20 |
0 |
2008-01-02 |
0 |
Premium* |
|
|
Genzyme Corp |
GENZ |
ExecVP,Chief Operating... |
2011-04-04 |
0 |
2011-04-04 |
0 |
Premium* |
|
|
Savient Pharmaceuticals Inc |
SVNTQ |
Director |
2013-01-07 |
12,644 |
|
0 |
Premium* |
|
|
Trevi Therapeutics, Inc. |
TRVI |
Director, 10% Owner |
2019-05-09 |
352,489 |
2019-05-09 |
341,239 |
Premium* |
|
|
Turmeric Acquisition Corp. |
TMPM |
Director |
2020-10-15 |
25,000 |
|
0 |
Premium* |
|
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
President and CEO, Dir... |
2024-03-19 |
174,605 |
2021-03-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
33 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GENZ |
Genzyme Corp |
President LSD TherapeuticsOffi |
• – – |
2008-05-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,886 |
|
- |
|
| GENZ |
Genzyme Corp |
President LSD TherapeuticsOffi |
• – – |
2008-05-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,339 |
|
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2013-01-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,644 |
|
- |
|
| TMPM |
Turmeric Acquisition Corp... |
Director |
– • – |
2020-10-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2007-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2008-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
26,000 |
0 |
- |
|
| GENZ |
Genzyme Corp |
President LSD Therapeutics |
• – – |
2008-08-15 |
4 |
S |
$83.19 |
$1,479,950 |
D/D |
(17,790) |
1,886 |
0 |
- |
|
| GENZ |
Genzyme Corp |
President LSD Therapeutics |
• – – |
2008-08-15 |
4 |
OE |
$20.59 |
$366,296 |
D/D |
17,790 |
19,676 |
0 |
- |
|
| GENZ |
Genzyme Corp |
ExecVP,Therapeutics,Biosurgery |
• – – |
2009-04-23 |
4 |
B |
$51.95 |
$103,906 |
D/D |
2,000 |
4,227 |
2.74 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2010-01-04 |
4 |
A |
$0.00 |
$9,500 |
D/D |
9,612 |
9,612 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2010-04-01 |
4 |
A |
$3.46 |
$9,501 |
D/D |
2,746 |
38,358 |
0 |
- |
|
| GENZ |
Genzyme Corp |
ExecVP,Chief Operating Officer |
• – – |
2010-05-21 |
4 |
AS |
$49.06 |
$808,901 |
D/D |
(16,488) |
4,694 |
0 |
- |
|
| GENZ |
Genzyme Corp |
ExecVP,Chief Operating Officer |
• – – |
2010-05-21 |
4 |
OE |
$26.50 |
$436,932 |
D/D |
16,488 |
21,182 |
0 |
- |
|
| GENZ |
Genzyme Corp |
ExecVP,Chief Operating Officer |
• – – |
2010-05-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,083 |
12,777 |
0 |
- |
|
| GENZ |
Genzyme Corp |
ExecVP,Chief Operating Officer |
• – – |
2010-05-25 |
4 |
S |
$45.60 |
$124,579 |
D/D |
(2,732) |
10,045 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2010-09-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(38,358) |
0 |
0 |
- |
|
| GENZ |
Genzyme Corp |
ExecVP,Chief Operating Officer |
• – – |
2011-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,250 |
39,801 |
0 |
- |
|
| GENZ |
Genzyme Corp |
ExecVP,Chief Operating Officer |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$780,774 |
D/D |
(10,551) |
29,250 |
0 |
- |
|
| GENZ |
Genzyme Corp |
ExecVP,Chief Operating Officer |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$2,164,500 |
D/D |
(29,250) |
0 |
0 |
- |
|
| GENZ |
Genzyme Corp |
ExecVP,Chief Operating Officer |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$98,124 |
I/I |
(1,326) |
0 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2013-01-07 |
4 |
A |
$1.17 |
$14,793 |
D/D |
12,644 |
12,644 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Director |
– • • |
2019-05-09 |
4 |
B |
$10.00 |
$112,500 |
D/D |
11,250 |
352,489 |
3.92 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Director |
– • • |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
300,536 |
300,536 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Director |
– • • |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
I/I |
40,703 |
341,239 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
President and CEO |
• • – |
2021-03-30 |
4 |
B |
$20.17 |
$201,713 |
D/D |
10,000 |
111,335 |
2.81 |
% |
|
33 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
